predominant
[용어속성] Term
First COVID-19 case in Zambia – Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries
잠비아 최초의 COVID-19 사례 - 아프리카 국가에서 발견된 SARS-CoV-2의 비교 계통 분석
Case Reports
[키워드] activity
African
Analysis
applied
B.1
B.1.1 lineage
caused
China
Community
Comparative
Contact tracing
country
COVID-19
COVID-19 case
Diagnosis
Disease surveillance
Epidemic
epidemic disease
Europe
Evolution of SARS-CoV-2
France
genome sequence
Health care
Health care worker
health care workers
incidence of COVID-19
individual
initial
Lineage
lineage B.1.1
MONITOR
National
Novel coronavirus
novel coronavirus SARS-CoV-2
phylogenetic analyses
predominant
preparation
resulting
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 strain
SARS-CoV-2 strains
South Africa
Spread
spread to
Surveillance
sustained
the patient
Travel
while
Wuhan
Wuhan, China
Zambia
[DOI] 10.1016/j.ijid.2020.09.1480 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.ijid.2020.09.1480 PMC 바로가기 [Article Type] Case Reports
High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer
Observational Study
[키워드] active malignancy
anorexia
Cancer
cancer patient
Cancer patients
Coronavirus disease-19
COVID-19
diarrhea
elevated
Elevation
evaluated
Fever
Gastrointestinal
GI symptom
had no
Hospitalized
hospitalized COVID-19 patient
hospitalized patient
initial symptom
liver transaminase
manifestation
Massachusett
material
multicenter cohort study
occur
oncology patients
Patient
patients
patients hospitalized
Patients with cancer
performed
predominant
presenting
Prevalence
prevalent
reported
respiratory symptoms
SARS-COV-2 infection
severity
subset
Symptom
transaminase
vomiting
with COVID-19
[DOI] 10.1097/MCG.0000000000001462 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1097/MCG.0000000000001462 PMC 바로가기 [Article Type] Observational Study
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation
SARS-CoV-2 스파이크 D614G 돌연변이의 진화 역학에 대한 ACE2 발현의 유전적 다양성의 영향
Communication
[키워드] absence
ACE2
ACE2 expression
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
adaptive
African
angiotensin
Antiviral treatment
Asian
binding
China
circulating
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
D 614G
D614G
D614G mutation
D614G variant
domain
driving
dynamic
Dynamics
Efficiency
enzyme
Europe
European
Evolution
Evolution of SARS-CoV-2
fusion
genetic diversity
Genetic variation
genetics
glycoprotein
human population
idea
Impact
increase in
measure
Mutation
North
North America
open
pandemic
Population
Population genetics
populations
Positive selection
predominant
public health
RBD
respiratory
Result
S glycoprotein
SARS-CoV-2
selective pressure
selective pressures
severe acute respiratory syndrome Coronavirus
spike
Support
the SARS-CoV-2
Transmissibility
Transmission
understanding
variant
Variation
variations
Viral
viral evolution
[DOI] 10.3390/genes12010016 PMC 바로가기 [Article Type] Communication
[DOI] 10.3390/genes12010016 PMC 바로가기 [Article Type] Communication
The Effect of the COVID-19 Pandemic on Emergency Department Visits for Neurological Diseases in Saudi Arabia
Neurology
[키워드] activities
activity
affected
Analysis
Brain
changed
chi-square test
Chronic diseases
condition
conditions
conducted
contributed
COVID-19
COVID-19 infection
COVID-19 pandemic
CT scans
decrease
demographic data
Department
diagnosis of COVID-19
disease
Effect
Emergency
epilepsy
example
Factor
headache
Hospitalization
hospitals
information
King
medical record
MOST
Multiple
neurological
Neurological symptom
new virus
other variable
pandemic
Patient
Perspective
predominant
raise
recorded
reduction in
Result
retrospective
Saudi Arabia
Seizures
shown
stroke
Topic
university
variable
virus
was performed
weakness
weakness. emergency visits
[DOI] 10.7759/cureus.12200 PMC 바로가기 [Article Type] Neurology
[DOI] 10.7759/cureus.12200 PMC 바로가기 [Article Type] Neurology
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
SARS-CoV-2 폐렴 치료를 위한 토실리주맙의 자비로운 사용
Article
Published on
Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 신약개발, 진단, 치료기술,
Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 신약개발, 진단, 치료기술,
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adverse
adverse events
anti-IL-6R
antigen receptor
appear
approved
benefit
C-reactive protein
C-reactive protein (CRP
chimeric antigen receptor
clinical and laboratory parameters
clinical trials
compassionate use
coronavirus
COVID-19
CRP
cytokine
Cytokine storm
death
Decline
declines
dose
drug
Drug administration
Efficacy
event
examined
Follow-up
food
Food and Drug Administration
hospitalized patient
hospitalized patients
IL-6
IL-6R
Inflammation
interleukin
interleukin 6
Intubated
laboratory parameter
Laboratory parameters
mechanical ventilation
morbidity
morbidity and mortality
Mortality
occurred
offer
outcomes
oxygen
Oxygen requirements
oxygen saturation
oxygen saturations
oxygen support
pathogenic
Patient
patients
patients with SARS-CoV-2
Placebo
placebo-controlled
Pneumonia
predominant
Preliminary data
profiles
proof
Randomized
rationale
reducing
required
respiratory
respiratory distress
Respiratory distress syndrome
SARS-CoV-2
SARS-CoV-2 pneumonia
SARS-CoV2
Serious Adverse Event
Serious Adverse Events
severe acute respiratory syndrome Coronavirus
Significant reduction
significant reductions
single-center study
supported
T-cell
temperature
therapy
Tocilizumab
Treatment
vasopressor requirement
vasopressor requirements
vasopressor support
[DOI] 10.1093/cid/ciaa812 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/cid/ciaa812 PMC 바로가기 [Article Type] Article
Clinical Characteristics of 47 Death Cases With COVID-19: A Retrospective Study at a Tertiary Center in Lahore
Internal Medicine
[키워드] acute respiratory distress
addition
age
alveolar
analyzed
Antibiotics
anticoagulation
antimicrobial
antiviral therapy
approval
ARDS
assessment
Asymptomatic
Bilateral
biochemical
BMI
C-reactive protein (CRP
calculate
center
Chest
Chronic kidney disease
clinical
Clinical characteristics
Clinical features
Cohort
Combination
Comorbidity
conducted
Coronavirus disease 2019
cough
COVID-19
COVID-19 patient
D-dimer
death
demonstrated
diabetes
died
disease course
drugs
Efficacy
elevated
epidemiological
evaluated
ferritin
Fever
FIVE
Gastrointestinal symptom
glucocorticoid
Ground-glass opacities
had no
hypertension
IBM
involved
ischemic heart disease
life-threatening
lung
lung field
lung involvement
male
male-to-female ratio
management
Mortality
Most patient
Neutrophil-to-lymphocyte ratio
nine
outcome
pandemic
pathology
Patient
patients
percentage
plasma
poor prognosis
positive
predict
predictors
predominant
prevalent
radiological
radiological features
Remdesivir
reported
Result
retrospective
severe disease
Shortness of breath
significantly
SPSS
sputum
Symptom
Symptoms
syndrome
Teaching
Tertiary
the mean
the patient
Tocilizumab
Treatment
university
was used
were given
[DOI] 10.7759/cureus.12039 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.12039 PMC 바로가기 [Article Type] Internal Medicine
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications
Cell and Developmental Biology
[키워드] ACE2
acute respiratory syndrome
antiviral drug
clinician
Complication
coronavirus
COVID-19
COVID-19 patients
dry cough
Guillain–Barrè syndrome
highlight
immune
immunomodulatory therapy
IMPROVE
induce
Infection
Inflammation
Inflammatory response
management
manifestation
mechanisms
MONITOR
multiple sclerosis
nervous system
Neurological complication
Neurological complications
neurological sign
predominant
respiratory
respiratory symptom
SARS-CoV-2
SARS-COV-2 infection
Specific
stroke
Supportive treatment
Treatment
virus
worldwide pandemic
[DOI] 10.3389/fcell.2020.605972 PMC 바로가기 [Article Type] Cell and Developmental Biology
[DOI] 10.3389/fcell.2020.605972 PMC 바로가기 [Article Type] Cell and Developmental Biology
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
SARS-CoV-2 폐 감염에 대한 숙주 반응의 시간적 및 공간적 이질성
Article
[키워드] Activation
Analysis
Autopsy
autopsy specimens
Cadaveric
Combination
death
disease
epithelial cell
Evolution
expression
Genes
heterogeneity
heterogeneous
high viral load
host response
immunohistochemistry
Inflammation
Inflammatory
inherent
interferon pathway
interferon response
lung
lung damage
Lungs
Macrophage
mucin
pathology
Patient
patients with COVID-19
platform
predominant
Protein
pulmonary epithelial cell
Pulmonary infection
RNA
RNA expression
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 virus
Severity of disease
specimen
Spectrum
surfactant
susceptibility
Temporal
the SARS-CoV-2 virus
tissue
Translational research
understanding
Viral
viral infection
Viral load
virus
virus infection
[DOI] 10.1038/s41467-020-20139-7 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-20139-7 PMC 바로가기 [Article Type] Article
A neonatal cluster of novel coronavirus disease 2019: clinical management and considerations
Case Reports
[키워드] affected
appear
Asymptomatic
blood test
Breastfeeding
Care
case sery
clinical condition
Clinical management
clinician
Cluster
continuous variable
coronavirus 2
COVID-19
debate
delivery
Descriptive statistics
disease
epidemiological situation
Evidence
FIVE
gastrointestinal tract
groups
hospital
Infection
Italy
joint
labor
Local
management
Mild
MONITOR
mother
Neonatal
Neonatal COVID-19
Neonate
neutropenia
Newborns
No complication
novel coronavirus disease
occurred
Older age
pandemic
Patient
positive
predominant
Pregnancy
public health
remained
reported
respiratory
Result
retrospective
risk of transmission
SARS-CoV-2
separated
Symptoms
tested
Transmission
unit
women
[DOI] 10.1186/s13052-020-00947-9 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s13052-020-00947-9 PMC 바로가기 [Article Type] Case Reports